1. ADRs related to unapproved clinical products: TGA changes

   News item 22 April 2017 Pages: 1 - 1

2. EMA review: continue to use selexipag as prescribed

   News item 22 April 2017 Pages: 2 - 2

3. EMA: new recommendations for single assessment of PSURs

   News item 22 April 2017 Pages: 3 - 3

4. MEDA recalls more EpiPen batches due to possible defect

   Media release 22 April 2017 Pages: 4 - 4

5. New online ADR reporting system launched in Italy

   News item 22 April 2017 Pages: 5 - 5

6. New policy adopted relating to alleged EMA improprieties

   News item 22 April 2017 Pages: 6 - 6

7. Risk of non-mandibular osteonecrosis with bevacizumab

   News item 22 April 2017 Pages: 7 - 7

8. Benzodiazepines in Alzheimers: increased risk of pneumonia

   Clinical study 22 April 2017 Pages: 8 - 8

9. DOACs: varied risk of gastrointestinal bleeding

   Clinical study 22 April 2017 Pages: 9 - 9

10. Recurrent upper GI bleeding with celecoxib or naproxen

    Clinical study 22 April 2017 Pages: 10 - 10

11. Venous thromboembolism: drospirenone vs levonorgestrel

    Clinical study 22 April 2017 Pages: 11 - 11

12. Acenocoumarol

    Case report 22 April 2017 Pages: 12 - 12

13. Aciclovir

    Case report 22 April 2017 Pages: 13 - 13

14. Acitretin

    Case report 22 April 2017 Pages: 14 - 14

15. Adalimumab

    Case report 22 April 2017 Pages: 15 - 15

16. Adalimumab/methotrexate

    Case report 22 April 2017 Pages: 16 - 16

17. Aesculus hippocastanum/ginkgo biloba extract interaction

    Case report 22 April 2017 Pages: 17 - 17

18. Aflibercept/bevacizumab/ranibizumab

    Case report 22 April 2017 Pages: 18 - 18

19. Ajmaline

    Case report 22 April 2017 Pages: 19 - 19

20. Alcohol

    Case report 22 April 2017 Pages: 20 - 20

21. Alectinib/ceritinib/lorlatinib

    Case report 22 April 2017 Pages: 21 - 21

22. Alemtuzumab

    Case report 22 April 2017 Pages: 22 - 22

23. Alemtuzumab

    Case report 22 April 2017 Pages: 23 - 23

24. Alemtuzumab

    Case report 22 April 2017 Pages: 24 - 24

25. Allopurinol

    Case report 22 April 2017 Pages: 25 - 25

26. Allopurinol/carbamazepine

    Case report 22 April 2017 Pages: 26 - 26

27. Alteplase

    Case report 22 April 2017 Pages: 27 - 27

28. Amiodarone

    Case report 22 April 2017 Pages: 28 - 28

29. Amiodarone

    Case report 22 April 2017 Pages: 29 - 29

30. Amiodarone/docetaxel/paclitaxel interactions

    Case report 22 April 2017 Pages: 30 - 30

31. Amisulpride/levodopa/benserazide

    Case report 22 April 2017 Pages: 31 - 31

32. Amoxicillin/clavulanic-acid

    Case report 22 April 2017 Pages: 32 - 32

33. Amphotericin B

    Case report 22 April 2017 Pages: 33 - 33

34. Amphotericin B liposomal

    Case report 22 April 2017 Pages: 34 - 34

35. Amphotericin B/voriconazole

    Case report 22 April 2017 Pages: 35 - 35

36. Antibacterials

    Case report 22 April 2017 Pages: 36 - 36

37. Antibiotics

    Case report 22 April 2017 Pages: 37 - 37

38. Anticoagulants

    Case report 22 April 2017 Pages: 38 - 38

39. Antiepileptic drugs

    Case report 22 April 2017 Pages: 39 - 39

40. Antineoplastics

    Case report 22 April 2017 Pages: 40 - 40

41. Antineoplastics

    Case report 22 April 2017 Pages: 41 - 41

42. Antineoplastics/mesna

    Case report 22 April 2017 Pages: 42 - 42

43. Antipsychotics

    Case report 22 April 2017 Pages: 43 - 43

44. Antiretrovirals

    Case report 22 April 2017 Pages: 44 - 44

45. Antivenin daboia russelli

    Case report 22 April 2017 Pages: 45 - 45

46. Apatinib

    Case report 22 April 2017 Pages: 46 - 46

47. Apatinib/carboplatin

    Case report 22 April 2017 Pages: 47 - 47

48. Aripiprazole

    Case report 22 April 2017 Pages: 48 - 48

49. Aripiprazole withdrawal

    Case report 22 April 2017 Pages: 49 - 49

50. Arsenic-trioxide

    Case report 22 April 2017 Pages: 50 - 50